Aromatase Inhibitors and Inactivators for the Treatment of Postmenopausal Breast Cancer: A Review

Publisher： Bentham Science Publishers

E-ISSN： 1875-6107|3|3|261-276

ISSN： 1568-0134

Source： Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol.3, Iss.3, 2003-09, pp. : 261-276

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Aromatase inhibitors continue their ATAC on tamoxifen

By Nicholls H.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 12-13

Elsevier

Access to resources Recommend Favorite

Antiangiogenic Agents in the Treatment of HER2-Negative Metastatic breast Cancer: A Brief Review

By  

Current Angiogenesis, Vol. 3, Iss. 2, 2014-07 ,pp. : 73-79

Bentham Science Publishers

Access to resources Recommend Favorite

Breast cancer screening in women: An integrative literature review

By Ravert Patricia K.   Huffaker Crystal  

Journal of the American Academy of Nurse Practitioners, Vol. 22, Iss. 12, 2010-12 ,pp. : 668-673

Blackwell Publishing

Access to resources Recommend Favorite

Expression of cyclin-dependent kinases and CDC25a phosphatase is related with recurrences and survival in women with peri- and post-menopausal breast cancer

By Bonin Serena   Brunetti Davide   Benedetti Elena   Gorji Nader   Stanta Giorgio  

Virchows Archiv, Vol. 448, Iss. 5, 2006-05 ,pp. : 539-544

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of Postmenopausal Osteoporosis

By  

Comprehensive Therapy, Vol. 33, Iss. 3, 2007-09 ,pp. : 114-119

Humana Press, Inc

Access to resources Recommend Favorite